BSE filing, NSE: NATIONSTD. Summary written from the filing by ALFA Finder's alert engine.
National Standard (India) Ltd: key numbers
- Share price
- ₹105.70
- Market cap
- ₹211.4 Cr
- Revenue (annual)
- ₹20.42 Cr
- Net profit (annual)
- ₹9.66 Cr
- P/E (TTM)
- 20.5×Sector 34.0×
- Promoter holding
- 73.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from National Standard (India) Ltd
All →National Standard (India) Q2 FY27 Results: Net Profit ₹3.3 Cr, Down 23.3% YoY
National Standard (India) Ltd reported net profit of ₹3.3 Cr (-23.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3.3 Cr · -23.3% YoY
National Standard (India) Board Meeting Date
National Standard (India) Ltd intimated BSE that its Board will meet on 22 Oct 2026 to consider Q1/H1 FY27 results. No financial figures are disclosed in this advance notice.
National Standard (India) Acquisition
National Standard (India) Ltd shareholders approved the scheme of merger by absorption with Lodha Developers Limited at the NCLT-convened meeting.
National Standard (India) Merger & Restructuring
National Standard (India) Limited issued a notice for an NCLT-convened shareholder meeting on October 9, 2026, to approve the scheme of merger.
National Standard (India) Acquisition
National Standard (India) Ltd issued notice for an NCLT-convened shareholder meeting on October 09, 2026, to consider its proposed merger with Lodha Developers Ltd.
National Standard (India) Annual General Meeting
National Standard (India) Ltd successfully concluded its 63rd Annual General Meeting on August 28, 2026. All proposed business items were passed by the requisite majority.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.